NCT06789172OKN4395solid tumorscancerPGE2PGD2
…clinical development of OKN4395, currently in a Phase 1 trial ( NCT06789172), as a novel immunotherapy for solid tumors, both as a standalo…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT06789172 ×
NCT06789172
This institution is selected. Its supporting articles are shown below.